Joanna Masel<p>Our latest <a href="https://ecoevo.social/tags/epidemiology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epidemiology</span></a> paper <a href="https://www.sciencedirect.com/science/article/pii/S1755436524000732" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">sciencedirect.com/science/arti</span><span class="invisible">cle/pii/S1755436524000732</span></a> shows that PCR <a href="https://ecoevo.social/tags/MassTesting" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MassTesting</span></a> could control many versions of a future respiratory <a href="https://ecoevo.social/tags/pandemic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>pandemic</span></a>, not just <a href="https://ecoevo.social/tags/SarsCoV2" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>SarsCoV2</span></a>, at low societal cost. We also explore logistics. Even a prototype would be really nice now with <a href="https://ecoevo.social/tags/H5N1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>H5N1</span></a>. 1/9</p>